This inventor holds 29 USPTO granted patents and 12 published patent applications, plus 5 CIPO patents and 4 EPO patents, primarily in Vaccine Nanotechnology. Top assignees: Harvard College, The Brigham and Women's Hospital, Inc., Massachusetts Institute of Technology. Active years: 2001-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boston, MA (US) (2005)
- Brookline, MA (US) (2001 - 2019)
- Chestnut Hill, MA (US) (2012 - 2023)
Company Filing History:
25 out of 3,075 
22 out of 1,428 
19 out of 8,586 
Years Active: 2001-2025
Areas of Expertise:
Title:
Ulrich H Von Andrian: Pioneering Innovations in Vaccine Nanotechnology
Introduction:
Ulrich H Von Andrian, based in Chestnut Hill, MA, is a visionary inventor whose passion for innovation in the realm of science and technology has propelled him to the forefront of cutting-edge research. With an impressive portfolio of 20 patents, Von Andrian continues to push the boundaries of what is possible, leaving a lasting impact on the field of immunology and vaccine development.
Latest Patents:
One of Von Andrian's latest patents revolves around vaccine nanotechnology. This groundbreaking invention focuses on delivering nanocarriers to immune system cells, stimulating immune responses in T cells and B cells. The inventive vaccine nanocarriers include immunomodulatory agents, targeting moieties, and immunostimulatory agents, paving the way for novel approaches in prophylaxis and treatment of various diseases and disorders.
Another notable patent by Von Andrian involves the delivery of biomolecules to immune cells. This method and device allow for the preferential delivery of compounds, such as antigens, to the cytosol of immune cells, enhancing the efficiency of immunotherapy and targeted treatments.
Career Highlights:
Ulrich H Von Andrian's illustrious career has seen him collaborate with prestigious institutions such as Harvard University and the Massachusetts Institute of Technology (MIT). His innovative research at these renowned establishments has garnered international recognition and acclaim, solidifying his reputation as a trailblazer in the field of immunology.
Collaborations:
Throughout his career, Von Andrian has collaborated with esteemed individuals in the scientific community, including Matteo Iannacone and Pamela A Basto. These collaborations have led to groundbreaking discoveries and advancements in vaccine technology, fostering a culture of innovation and excellence in research.
Conclusion:
Ulrich H Von Andrian's relentless dedication to pushing the boundaries of innovation in vaccine nanotechnology has positioned him as a visionary inventor in the realm of science and technology. His pioneering work continues to inspire future generations of inventors and researchers, shaping the landscape of immunology and healthcare for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile